<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01869738</url>
  </required_header>
  <id_info>
    <org_study_id>IMD-10</org_study_id>
    <nct_id>NCT01869738</nct_id>
  </id_info>
  <brief_title>MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction</brief_title>
  <acronym>MASTER-II</acronym>
  <official_title>MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InspireMD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InspireMD</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of the MGuard™ Prime stent in the treatment of blocked
      arteries in coronary arteries in patients undergoing a stenting procedure due to having a
      heart attack. The MGuard Prime stent wil be compared to other FDA approved bare-metal (BMS)
      or drug-eluting (DES) coronary stents. The hypotheses are that (1) the MGuard Prime stent
      will achieve a higher rate of complete ST-segment resolution as seen on the post-procedure
      ECG as compared to the comparator stent, and will have a similar effect on the rate of
      all-cause death or recurrent target vessel myocardial infarction at 365 days post-procedure.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    low enrollment rate
  </why_stopped>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rate of complete ST-segment resolution within 60-90 minutes</measure>
    <time_frame>60-90 minutes post-procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The primary safety endpoint is a composite of all-cause death or recurrent target vessel myocardial infarction (TV re-MI) at 365 days post-procedure, powered to demonstrate non-inferiority of the MGuard™ Prime Stent compared to the control arm.</measure>
    <time_frame>365 days post-procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infarct size assessed by cardiac magnetic resonance imaging (MRI)</measure>
    <time_frame>5 days post-procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-stent late lumen loss (LLL)</measure>
    <time_frame>13 months post-procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">310</enrollment>
  <condition>ST Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>MGuard Prime</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MGuard Prime stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(BMS/DES) Includes FDA approved bare metal or drug eluting stents, including ENDEAVOR, TAXUS Liberte, XIENCE Prime, PROMUS Element, ION, RESOLUTE, Driver, Vision, VeriFlex and Integrity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MGuard Prime</intervention_name>
    <arm_group_label>MGuard Prime</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>(BMS/DES)</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is more than 18 years of age

          -  Subject is experiencing clinical symptoms consistent with acute myocardial infarction
             (AMI) of more than 30 minutes and less than 12 hours in duration.

          -  ST elevation more than 2 mm per lead in more than 2 contiguous leads is present in one
             ECG prior to consent.

          -  Subject agrees to all required follow-up procedures and visits.

          -  Subject or legal representative provides written, informed consent.

          -  The target lesion is a de novo lesion in a native coronary artery.

          -  Based on coronary anatomy, PCI is indicated for the culprit lesion with anticipated
             use of stenting.

          -  The reference vessel diameter (RVD) of the infarct lesion is 2.75 to 4.0 mm by visual
             assessment, assessed either at baseline (if direct stenting is planned), or after
             pre-dilatation or thrombus aspiration (if direct stenting is not planned).

          -  The entire lesion length requiring treatment is less than 24 mm (able to be covered by
             a single study stent), assessed either at baseline (if direct stenting is planned), or
             after pre-dilatation or thrombus aspiration (if direct stenting is not planned)

          -  TIMI flow of 2/3 is present prior to randomization (in case of baseline TIMI flow 0/1,
             blood flow must be restored).

        Exclusion Criteria:

          -  Left bundle branch block (LBBB), paced rhythm, or other ECG abnormality interfering
             with assessment of ST-segment.

          -  Currently enrolled in another investigational device or drug trial that has not
             completed the primary endpoint or that clinically interferes with the current study
             endpoints.

          -  A previous coronary interventional procedure of any kind within 30 days prior to the
             procedure.

          -  Female patients of childbearing potential.

          -  Subject undergoing cardiopulmonary resuscitation (patients in whom cardiopulmonary
             resuscitation was successfully performed and in whom normal mental status was
             achieved, may be enrolled).

          -  Cardiogenic shock (SBP less than 80 mmHg for more than other hemodynamic support
             device for hypotension).

          -  The subject requires a staged procedure of the target vessel (including branches)
             within 12 months or of any non-target vessel within 7 days post-procedure.

          -  The target lesion requires treatment with a device other than PTCA prior to stent
             placement (such as, but not limited to excimer laser, rotational atherectomy, etc.).
             Manual thrombus aspiration may be used per operator discretion, but rheolytic
             thrombectomy is only permitted for procedural complications after randomization.

          -  Prior administration of thrombolytic therapy for the current admission

          -  Co-morbid condition(s) that could limit the subject's ability to participate in the
             trial or to comply with follow-up requirements, or impact the scientific integrity of
             the trial.

          -  Concurrent medical condition with a life expectancy of less than 12 months.

          -  History of cerebrovascular accident or transient ischemic attack within the last 6
             months, or any permanent neurologic deficit

          -  Prior intracranial bleed at any time, or known intracranial pathology (e.g. tumor,
             arteriovenous malformation, or aneurysm).

          -  Active or recent site of major bleeding within 6 months.

          -  History of bleeding diathesis or coagulopathy or inability to accept blood
             transfusions.

          -  Known hypersensitivity or contraindication to either i) aspirin, or heparin and
             bivalirudin; or ii) clopidogrel , ticlopidine, prasugrel and ticagrelor; or iii)
             cobalt or nickel; or iv) contrast media, which cannot be adequately pre-medicated
             (prior anaphylaxis, however, is an absolute contraindication to enrollment).

          -  Known serum creatinine level more than 2.5 mg/dl, hemoglobin less than 10 g/dL or
             platelet count less than 150,000 for the present admission or within 7 days prior to
             index procedure, if available.

          -  Surgery planned or any other reason necessitating discontinuation of dual
             anti-platelet therapy (aspirin and an ADP antagonist) within 12 months

          -  Aortic dissection or mechanical complication of STEMI

          -  Unprotected left main stenosis more than 50%.

          -  Multi-vessel intervention required during the index procedure.

          -  Excessive tortuosity, calcification or diffuse distal disease

          -  A non-infarct lesion with stenosis more than 50% is present in the target vessel

          -  Target lesion is a bifurcation with a side branch more than 2.0 mm in diameter.

          -  Target lesion at the site of or within a vessel with a previously implanted stent

          -  Target lesion is within a bypass graft conduit, or can only be reached by passing the
             study stent through a bypass graft conduit

          -  In the Investigator's opinion the lesion/vessel is unsuitable for treatment with the
             study stent for any reason.

          -  The lesion requires use of atherectomy, thrombectomy (not including manual thrombus
             aspiration catheters), laser devices, or proximal or distal embolic protection devices
             prior to randomization.

          -  Aortic dissection or mechanical complication of STEMI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pepin Heart Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alexian Brothers Medical Center</name>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Medical Group</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Union Memorial Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Southern Maryland Hospital Center</name>
      <address>
        <city>Clinton</city>
        <state>Maryland</state>
        <zip>20735</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sparrow Clinical Research Institute</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48910</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of North Mississippi</name>
      <address>
        <city>Oxford</city>
        <state>Mississippi</state>
        <zip>38655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Hospital</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asheville Cardiology Associates</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elyria Memorial Hospital</name>
      <address>
        <city>Oberlin</city>
        <state>Ohio</state>
        <zip>44074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Ohio Cardiology</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Spirit Hospital</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Clinic Cardiology</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winchester Medical Center</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ZNA Antwerpem</name>
      <address>
        <city>Antwerp</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University hospital</name>
      <address>
        <city>Hradec Kralove</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Na Homolce Hospital</name>
      <address>
        <city>Prague</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North-Estonia Regional Hospital</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Louis Pradel</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Jacques Cartier</name>
      <address>
        <city>Massy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpitaux GHI Le Raincy - Montfermeil</name>
      <address>
        <city>Montfermeil</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôptal Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Universitätsklinikum Berlin Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Universitätsklinikum Berlin Campus Virchow</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stadtische Kliniken München</name>
      <address>
        <city>Munich</city>
        <zip>81925</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Brüder</name>
      <address>
        <city>Trier</city>
        <zip>54292</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitat Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petach Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouwe Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <state>AC</state>
        <zip>1091</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Schweitzerziekenhuis</name>
      <address>
        <city>Dordrecht</city>
        <zip>3318</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Malopolskie Centrum Sercowo-Naczyniowe</name>
      <address>
        <city>Chrzanow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polsko-Amerykańskie Kliniki Serca</name>
      <address>
        <city>Dąbrowa Górnicza</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Górnośląskie Centrum Medyczne</name>
      <address>
        <city>Katowice</city>
        <zip>40-635</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krakowskie Centrum Kardiologii Inwazyjnej</name>
      <address>
        <city>Krakow</city>
        <zip>30-693</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersyteckiw Krakowie</name>
      <address>
        <city>Krakow</city>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Paul II Hospital</name>
      <address>
        <city>Krakow</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Kardiologii i Angiologii Interwencyjnej</name>
      <address>
        <city>Warsaw</city>
        <zip>04 - 628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katedra i Klinika Kardiologii Uniwersytetu Medycznego w Łodzi</name>
      <address>
        <city>Łódź</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic, University of Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bellvitge University Hospital</name>
      <address>
        <city>Barcelona</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Madrid Montepríncipe</name>
      <address>
        <city>Madrid</city>
        <zip>28660</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bristol Heart Institute</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Wales</name>
      <address>
        <city>Cardiff</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee National Hospital</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Southampton NHS Foundation Trust</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Czech Republic</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2013</study_first_submitted>
  <study_first_submitted_qc>June 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2013</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart attack</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 23, 2017</submitted>
    <submission_canceled>Unknown</submission_canceled>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

